ao link
Who's Who Legal
Who's Who Legal
Menu
Thought Leaders

Thought Leaders

Thought Leader

WWL Ranking: Thought Leader

Global Leader

Corporate Governance 2021

Professional Biography

WWL Ranking: Recommended

WWL says

Andrew Brownstein is lauded for his first-rate corporate practice and expertise advising clients on governance-related issues.

Biography

Andrew R Brownstein has been a partner at Wachtell, Lipton, Rosen & Katz since 1985 and serves as co-chair of the firm’s corporate group. His practice concentrates on mergers and acquisitions and corporate governance matters, and he has been engaged in many high-profile matters that include cross-border transactions, leveraged buyouts, complex restructuring deals, proxy fights and takeovers. Mr Brownstein is consistently listed in the top ranks in his areas of expertise by the Chambers Guide, Who’s Who Legal and other similar publications.

Mr Brownstein’s significant representations include: Allergan in its pending $83 billion acquisition by AbbVie; Hewlett Packard in its separation into two new publicly traded Fortune 50 companies; Hewlett Packard Enterprise in its $1.3 billion acquisition of Cray, a $2.6 billion Reverse Morris Trust transaction with Micro Focus International, and its $1 billion acquisition of Nimble Storage; Perrigo in its defence against a takeover bid by Mylan; Johnson Controls in its $16.3 billion merger with Tyco and the separation of its automotive business; Valspar in its $11.3 billion acquisition by Sherwin-Williams; Univar in its $2 billion acquisition of Nexeo Solutions, and in the $640 million sale of Nexeo Plastics to One Rock Capital Partners; Walgreen Co. in its two-step acquisition of Alliance Boots GmbH for an aggregate value of approximately $27 billion; ServiceMaster in connection with the spin-off of Frontdoor; ConocoPhillips in its $33 billion spin-off of its downstream businesses as Phillips 66, and in its $35.6 billion acquisition of Burlington Resources; Phillips Petroleum in its $35 billion combination with Conoco; Forest Laboratories in successive proxy contests with Carl Icahn and its $25 billion merger with Actavis; Genzyme in its $20 billion sale to Sanofi-Aventis; Novartis in its $49.7 billion multistep acquisition of Alcon; and Schering-Plough in its $41 billion combination with Merck.

Mr Brownstein is a 1979 honours graduate of Harvard Law School where he was an articles editor of the Harvard Law Review. He holds an MBA degree (1976) from the Wharton School of the University of Pennsylvania and also has undergraduate degrees in English and economics (1975) from the University of Pennsylvania, where he was elected to Phi Beta Kappa. Following law school, Mr Brownstein clerked for the Honorable Leonard I. Garth of the US Court of Appeals for the Third Circuit.

Mr Brownstein is a frequent author and lecturer on corporate-related topics. He has been an adjunct professor of securities law at Rutgers University Law School, serves on the executive planning committee and is past chairman of the Ray Garrett Jr Corporate and Securities Law Institute at Northwestern University School of Law.

Mr Brownstein is active in numerous civic and charitable organisations and is a member and past president of the board of trustees of the Trinity School in New York City, a member of the board of overseers of the Annenberg Center at the University of Pennsylvania and a member of the board of directors of the New York City Public Art Fund.

M&A 2021

Professional Biography

WWL Ranking: Recommended

WWL says

Andrew Brownstein is a well-established name in the US market, admired for his wealth of experience on a range of M&A deals.

Biography

Andrew R Brownstein has been a partner at Wachtell, Lipton, Rosen & Katz since 1985 and serves as co-chair of the firm’s corporate group. His practice concentrates on mergers and acquisitions and corporate governance matters, and he has been engaged in many high-profile matters that include cross-border transactions, leveraged buyouts, complex restructuring deals, proxy fights and takeovers. Mr Brownstein is consistently listed in the top ranks in his areas of expertise by the Chambers Guide, Who’s Who Legal and other similar publications.

Mr Brownstein’s significant representations include: Allergan in its pending $83 billion acquisition by AbbVie; Hewlett Packard in its separation into two new publicly traded Fortune 50 companies; Hewlett Packard Enterprise in its $1.3 billion acquisition of Cray, a $2.6 billion Reverse Morris Trust transaction with Micro Focus International, and its $1 billion acquisition of Nimble Storage; Perrigo in its defence against a takeover bid by Mylan; Johnson Controls in its $16.3 billion merger with Tyco and the separation of its automotive business; Valspar in its $11.3 billion acquisition by Sherwin-Williams; Univar in its $2 billion acquisition of Nexeo Solutions, and in the $640 million sale of Nexeo Plastics to One Rock Capital Partners; Walgreen Co. in its two-step acquisition of Alliance Boots GmbH for an aggregate value of approximately $27 billion; ServiceMaster in connection with the spin-off of Frontdoor; ConocoPhillips in its $33 billion spin-off of its downstream businesses as Phillips 66, and in its $35.6 billion acquisition of Burlington Resources; Phillips Petroleum in its $35 billion combination with Conoco; Forest Laboratories in successive proxy contests with Carl Icahn and its $25 billion merger with Actavis; Genzyme in its $20 billion sale to Sanofi-Aventis; Novartis in its $49.7 billion multistep acquisition of Alcon; and Schering-Plough in its $41 billion combination with Merck.

Mr Brownstein is a 1979 honours graduate of Harvard Law School where he was an articles editor of the Harvard Law Review. He holds an MBA degree (1976) from the Wharton School of the University of Pennsylvania and also has undergraduate degrees in English and economics (1975) from the University of Pennsylvania, where he was elected to Phi Beta Kappa. Following law school, Mr Brownstein clerked for the Honorable Leonard I. Garth of the US Court of Appeals for the Third Circuit.

Mr Brownstein is a frequent author and lecturer on corporate-related topics. He has been an adjunct professor of securities law at Rutgers University Law School, serves on the executive planning committee and is past chairman of the Ray Garrett Jr Corporate and Securities Law Institute at Northwestern University School of Law.

Mr Brownstein is active in numerous civic and charitable organisations and is a member and past president of the board of trustees of the Trinity School in New York City, a member of the board of overseers of the Annenberg Center at the University of Pennsylvania and a member of the board of directors of the New York City Public Art Fund.

Law Business Research
Law Business Research Ltd
Meridian House, 34-35 Farringdon Street
London EC4A 4HL, UK
© Law Business Research Ltd 1998-2021. All rights reserved.
Company No.: 03281866